Atlas Trials

A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients

Clinical trial NCT05956418 · RECRUITING

Trial details

NCT number
NCT05956418
Sponsor
Pharmazz, Inc.
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Hypovolemic Shock
Start date
2021-08-13
Primary completion
2026-06-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.